Avadel Pharmaceuticals【AVDL】株式ニュース

名称	銘柄コード	市場	種別
Avadel Pharmaceuticals PLC	AVDL	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.12	-0.79%	15.13	13:00:07

始値	安値	高値	終値	前日終値
15.3112	14.95	15.60	15.13	15.25

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/30	21:00	GLOBE	Avadel Pharmaceuticals to Present at Upcoming Investor..
2024/5/22	21:00	GLOBE	Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate)..
2024/5/22	06:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/22	06:27	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/5/21	20:04	EDGAR2	Form 8-K - Current report
2024/5/21	20:00	GLOBE	Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its..
2024/5/18	05:18	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/5/09	05:17	EDGAR2	Form 8-K - Current report
2024/5/09	05:06	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/08	22:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/08	21:29	IHMARKETNEWS	U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet..
2024/5/08	20:08	EDGAR2	Form 8-K - Current report
2024/5/08	20:00	GLOBE	Avadel Pharmaceuticals Provides Corporate Update and Reports..
2024/5/01	21:00	GLOBE	Avadel Pharmaceuticals to Provide a Corporate Update and..
2024/4/01	21:00	GLOBE	Avadel Pharmaceuticals to Present at the 23rd Annual Needham..
2024/3/05	22:00	GLOBE	Avadel Pharmaceuticals to Present at Upcoming Investor..
2024/3/05	05:51	EDGAR2	Form 8-K - Current report
2024/3/05	05:37	GLOBE	Avadel Pharmaceuticals Issues Statement On Patent Litigation
2024/3/04	20:35	EDGAR2	Form 8-K - Current report
2024/3/04	20:30	GLOBE	Avadel Pharmaceuticals Provides Corporate Update and Reports..
2024/3/04	20:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/04	20:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/04	20:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/26	22:00	GLOBE	Avadel Pharmaceuticals to Provide a Corporate Update and..
2024/2/14	21:11	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	07:54	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	06:39	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/13	23:40	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/12	22:20	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/07	22:00	GLOBE	Avadel Pharmaceuticals to Present at the Oppenheimer 34th..
2024/1/17	06:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/08	21:20	EDGAR2	Form 8-K - Current report
2024/1/08	21:00	GLOBE	Avadel Pharmaceuticals Announces Strong LUMRYZ Launch..
2023/12/30	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/29	04:54	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/08	23:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08	21:09	EDGAR2	Form 8-K - Current report
2023/11/08	21:00	GLOBE	Avadel Pharmaceuticals Provides Corporate Update and Reports..
2023/11/07	22:00	GLOBE	Avadel Pharmaceuticals to Present at Upcoming Investor..
2023/10/30	21:00	GLOBE	Avadel Pharmaceuticals to Provide a Corporate Update and..
2023/10/20	21:00	GLOBE	Avadel Pharmaceuticals Announces Data Supporting Clinical..
2023/10/05	21:00	GLOBE	Avadel Pharmaceuticals to Present at the Jefferies Biotech..
2023/9/02	10:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/02	10:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/31	21:00	GLOBE	Avadel Pharmaceuticals to Present at Upcoming Investor..
2023/8/16	05:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	06:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/12	05:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/12	04:50	EDGAR2	Form 144 - Report of proposed sale of securities
2023/8/11	07:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..